Bernard Vanhove
Chief Operating Officer at Xenothera SAS
Bernard Vanhove active positions
| Companies | Position | Start | End |
|---|---|---|---|
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | Corporate Officer/Principal | - | - |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Corporate Officer/Principal | - | - |
Xenothera SAS
 Xenothera SAS BiotechnologyHealth Technology Xenothera SAS is a biotechnologies company. It creates therapeutic modes in numerous domains from immunomodulation to infectious diseases. The company was founded on June 30, 2014 and is headquartered in | Chief Operating Officer | - | - |
Career history of Bernard Vanhove
Former positions of Bernard Vanhove
| Companies | Position | Start | End |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Chief Operating Officer | 30/04/2016 | 30/11/2018 |
| Chief Tech/Sci/R&D Officer | 30/04/2016 | 30/11/2018 | |
Effimune SA
 Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France. | Chief Executive Officer | 25/08/2014 | - |
| Founder | 31/12/2006 | - |
Training of Bernard Vanhove
| Université Catholique de Louvain | Doctorate Degree |
Statistics
International
| France | 5 |
| United States | 2 |
| Belgium | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 4 |
| Government | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Private companies | 4 |
|---|---|
Effimune SA
Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France. | Health Technology |
Centre National de la Recherche Scientifique
Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | Government |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Commercial Services |
Xenothera SAS
Xenothera SAS BiotechnologyHealth Technology Xenothera SAS is a biotechnologies company. It creates therapeutic modes in numerous domains from immunomodulation to infectious diseases. The company was founded on June 30, 2014 and is headquartered in | Health Technology |
- Stock Market
- Insiders
- Bernard Vanhove
- Experience
